249 related articles for article (PubMed ID: 20352663)
1. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
[TBL] [Abstract][Full Text] [Related]
3. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
[TBL] [Abstract][Full Text] [Related]
4. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
[TBL] [Abstract][Full Text] [Related]
5. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
[TBL] [Abstract][Full Text] [Related]
6. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
[TBL] [Abstract][Full Text] [Related]
7. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
8. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
[TBL] [Abstract][Full Text] [Related]
9. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
[TBL] [Abstract][Full Text] [Related]
10. Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2011 Apr; 76(71):20518-24. PubMed ID: 21491808
[TBL] [Abstract][Full Text] [Related]
11. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
[TBL] [Abstract][Full Text] [Related]
12. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
Colker AC
NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
[No Abstract] [Full Text] [Related]
13. Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(251):96992-7044. PubMed ID: 28068052
[TBL] [Abstract][Full Text] [Related]
14. Exemption from import/export requirements for personal medical use. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
[TBL] [Abstract][Full Text] [Related]
15. Impacts of federal precursor chemical regulations on methamphetamine arrests.
Cunningham JK; Liu LM
Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
[TBL] [Abstract][Full Text] [Related]
16. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
[TBL] [Abstract][Full Text] [Related]
17. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
[TBL] [Abstract][Full Text] [Related]
18. Authorized sources of narcotic raw materials. Final rule.
Fed Regist; 2008 Feb; 73(25):6843-51. PubMed ID: 18389916
[TBL] [Abstract][Full Text] [Related]
19. Clarification of registration requirements for individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
[TBL] [Abstract][Full Text] [Related]
20. Controlled substances and List I chemical registration and reregistration fees. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2012 Mar; 77(51):15234-50. PubMed ID: 22420065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
